Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
595.10
-15.40 (-2.52%)
At close: Jun 13, 2025, 4:00 PM
599.00
+3.90 (0.66%)
After-hours: Jun 13, 2025, 7:59 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $7.74 billion as of June 13, 2025. Its market cap has increased by 9,851.50% in one year.
Market Cap
7.74B
Enterprise Value
7.74B
1-Year Change
9,851.50%
Ranking
Category
Stock Price
$595.10
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $7.74B, an increase of 6,347.92%. That is a compound annual growth rate of 190.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 7.74B | 11,946.56% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |